日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

一项关于塞培前列素与拉坦前列素治疗原发性开角型青光眼或眼高压患者的24小时疗效和安全性的研究

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03227-2
Konstas, Anastasios-Georgios; Garhöfer, Gerhard; Lübke, Jan; Voykov, Bogomil; Ropo, Auli
神经科学
青光眼
发表日期：2025
文献求助 收藏

Changing from preserved, to preservative-free cyclosporine 0.1% enhanced triple glaucoma therapy: impact on ocular surface disease-a randomized controlled trial

从含防腐剂的环孢素0.1%滴眼液改为不含防腐剂的环孢素0.1%滴眼液，可增强三联青光眼治疗：对眼表疾病的影响——一项随机对照试验

期刊:
影响因子:
doi:10.1038/s41433-023-02578-w
Konstas, Anastasios-Georgios; Boboridis, Konstadinos G; Athanasopoulos, Georgios P; Haidich, Anna-Bettina; Voudouragkaki, Irini C; Pagkalidou, Eirini; Katsanos, Andreas; Katz, L Jay
神经科学
青光眼
发表日期：2023
文献求助 收藏

Correction to: 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy

更正：对于使用含防腐剂的拉坦前列素单药治疗控制不佳的开角型青光眼患者，单独使用不含防腐剂的他氟前列素以及与不含防腐剂的多佐胺/噻吗洛尔固定复方制剂联合使用时，24 小时疗效和眼表健康状况

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-020-01316-y
Konstas, Anastasios-Georgios; Boboridis, Konstadinos G; Kapis, Paraskevas; Marinopoulos, Konstantinos; Voudouragkaki, Irini C; Panayiotou, Dimitrios; Mikropoulos, Dimitrios G; Pagkalidou, Eirini; Haidich, Anna-Bettina; Katsanos, Andreas; Quaranta, Luciano
神经科学
青光眼
发表日期：2020
文献求助 收藏

Rare Persistent Corneal Infection by Phoma sp. - A Case Report

罕见的由Phoma sp.引起的持续性角膜感染——病例报告

期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-019-0163-0
Adamopoulou, Aspasia; Sakellaris, Dimitris; Koronis, Spyridon; Balidis, Miltos; Zachariadis, Zachos; Tranos, Paris; Kozeis, Nikos; Gatzioufas, Zisis; Anogeianakis, George; Mikropoulos, Dimitrios G; Konstas, Anastasios-Georgios
炎症/感染
发表日期：2019
文献求助 收藏

Cyclodestructive Procedures in Glaucoma: A Review of Current and Emerging Options

青光眼睫状体破坏性手术：当前及新兴治疗方案综述

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-018-0837-3
Dastiridou, Anna I; Katsanos, Andreas; Denis, Philippe; Francis, Brian A; Mikropoulos, Dimitrios G; Teus, Miguel A; Konstas, Anastasios-Georgios
神经科学
青光眼
发表日期：2018
文献求助 收藏

24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy

在单用含防腐剂的拉坦前列素治疗控制不佳的开角型青光眼患者中，单独使用不含防腐剂的他氟前列素以及与不含防腐剂的多佐胺/噻吗洛尔固定复方制剂联合使用，24 小时疗效和眼表健康状况如何？

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-016-0448-9
Konstas, Anastasios-Georgios; Boboridis, Konstadinos G; Kapis, Paraskevas; Marinopoulos, Konstantinos; Voudouragkaki, Irini C; Panayiotou, Dimitrios; Mikropoulos, Dimitrios G; Pagkalidou, Eirini; Haidich, Anna-Bettina; Katsanos, Andreas; Quaranta, Luciano
神经科学
青光眼
发表日期：2017
文献求助 收藏

Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma

目前关于使用抗VEGF药物作为青光眼辅助治疗的观点

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-016-0461-z
Andrés-Guerrero, Vanessa; Perucho-González, Lucía; García-Feijoo, Julián; Morales-Fernández, Laura; Saenz-Francés, Federico; Herrero-Vanrell, Rocío; Júlvez, Luis Pablo; Llorens, Vicente Polo; Martínez-de-la-Casa, José María; Konstas, Anastasios-Georgios
VEGF
EGF
神经科学
青光眼
发表日期：2017
文献求助 收藏

Targeting Schlemm's Canal in the Medical Therapy of Glaucoma: Current and Future Considerations

青光眼药物治疗中以施莱姆氏管为靶点：现状与未来展望

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-017-0513-z
Andrés-Guerrero, Vanessa; García-Feijoo, Julián; Konstas, Anastasios Georgios
神经科学
青光眼
发表日期：2017
文献求助 收藏